Wang, X., Mathews, P., Nichols, K. R., Jabbar, S., Jensen, J., Huggis, J., … Kang, Y. (2023). Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Wang, Xiaobei, Parker Mathews, Krista Rowe Nichols, Shaima Jabbar, Johanna Jensen, Jonathan Huggis, Daniel Schrum, et al. “Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Wang X, Mathews P, Nichols KR, Jabbar S, Jensen J, Huggis J, et al. Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Wang, Xiaobei, et al. “Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Wang X, Mathews P, Nichols KR, Jabbar S, Jensen J, Huggis J, Schrum D, Eberwein E, Kennedy E, Kelsey CR, Choi T, McKinney M, Galal A, Kang Y. Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy. JOURNAL OF CLINICAL ONCOLOGY. 2023.